创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

JI Xiaoxia, LIU Hongxia, HE Chaoyong. Progress of Research on the Role of PDGF/PDGFR Signaling Pathway in Fibrotic Diseases[J]. Progress in Pharmaceutical Sciences, 2022, 46(2): 153-160.
Citation: JI Xiaoxia, LIU Hongxia, HE Chaoyong. Progress of Research on the Role of PDGF/PDGFR Signaling Pathway in Fibrotic Diseases[J]. Progress in Pharmaceutical Sciences, 2022, 46(2): 153-160.

Progress of Research on the Role of PDGF/PDGFR Signaling Pathway in Fibrotic Diseases

  • Fibrosis is the excessive deposition of extracellular matrix caused by excessive activation of fibroblasts stimulated by harmful factors. PDGF is one of the important mediators of fibrotic diseases, and activation of PDGF/PDGFR pathway is involved in the regulation of fibrosis of multiple organs such as heart, liver, kidney and skin. This paper reviews the research progress of PDGF/PDGFR signaling pathway in fibrotic diseases in order to provide reference for the treatment of fibrotic diseases.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return